ArticleCancer biology & therapy2017

Simultaneous targeting of ATM and Mcl-1 increases cisplatin sensitivity of cisplatin-resistant non-small cell lung cancer.

Fuquan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.